Skip to content
  • Home
  • About Us
  • Shop
    • Chinese innovative drug
    • Tablets
    • Capsules
    • Injection
    • oral solution
    • Cream/Gel/Ointment
    • ophthalmic preparations
    • Nasal preparations
    • Inhalation preparation
    • Implant
    • Chinese Medicine
  • Blog
  • Contact Us
Xpharma China
Shopping cart$0.00 0
Login
  • Home
  • About Us
  • Shop
    • Chinese innovative drug
    • Tablets
    • Capsules
    • Injection
    • oral solution
    • Cream/Gel/Ointment
    • ophthalmic preparations
    • Nasal preparations
    • Inhalation preparation
    • Implant
    • Chinese Medicine
  • Blog
  • Contact Us
Xpharma China
Ultibro Breezhaler (Indacaterol Maleate and Glycopyrronium Bromide Powder for Inhalation)
  • Drug news

How much does Ultibro Breezhaler (Indacaterol Maleate and Glycopyrronium Bromide Powder for Inhalation) Cost& price without insurance in China?

Vyndamax (Tafamidis Soft Capsules)
  • Drug news

How much does Vyndamax (Tafamidis Soft Capsules) Cost& price without insurance in China?

Vyndaqel (Tafamidis Meglumine Soft Capsules)
  • Drug news

How much does Vyndaqel (Tafamidis Meglumine Soft Capsules) Cost& price without insurance in China?

Tecfidera (Dimethyl Fumarate Enteric Capsules)
  • Drug news

How much does Tecfidera (Dimethyl Fumarate Enteric Capsules) Cost& price without insurance in China?

GILENYA (Fingolimod Hydrochloride Capsules)
  • Drug news

How much does GILENYA (Fingolimod Hydrochloride Capsules) Cost& price without insurance in China?

ZEPOSIA (Ozanimod Hydrochloride Capsules)
  • Drug news

How much does ZEPOSIA (Ozanimod Hydrochloride Capsules) Cost& price without insurance in China?

XTANDI (Enzalutamide Soft Capsules)
  • Drug news

How much does XTANDI (Enzalutamide Soft Capsules) Cost& price without insurance in China?

Symproic®Naldemedine
  • Drug news

Chia Tai Tianqing:Symproic®Naldemedine Tosylate and FOSUN PHARMA:AKYNZEO®NEPA have been approved for marketing in China

  • Drug development

Kelun-Biotech’s TROP2 ADC combined with immunotherapy as first-line treatment for NSCLC succeeds in Phase III study

Hengrui
  • Drug development

Hengrui Pharma Announces Positive Topline Results from China Phase 3 Type 2 Diabetes Study (OUTSTAND-1) of Oral Small-Molecule GLP-1 Receptor Agonist HRS-7535

  • Drug development

Henlius: First patient dosed in China in international multicenter study of pimurutamab (HLX07) combined with H drug Hetronifly®

  • Drug development

Eli Lilly & Co.: VERVE-102 Phase 1 Clinical Trial Success

Prev
1 … 15 16 17 18 19 20 21 22
Next
Contact us

WeChat: +86 139 2425 9988
WhatsApp : +852 9100 6363
Email: info@xpharma.com.cn

Rm F2-48, 6/F, No. 47 Guomao Road, Hainan, China

Useful Links
  • Medicines
  • Chinese innovative drug
  • Medicines Approved News
  • Drug Development News
  • Drug News
  • Privacy Policy
Email Newsletter

Subscribe to our newsletter and get 10% off your first purchase

Copyright © {2026} -Xpharma China